Medical Director/Medical Staff

Section 2060.415  Medical Director/Medical Staff a)         All organizations providing services authorized by a treatment license shall designate a medical director, licensed and in good standing, who shall oversee all medical requirements and procedures, as applicable and as referenced in this Part.  The medical director shall have the following staff qualification relative to each service or level of care specified below: 1)         The medical director for any Opioid Treatment Programs (OTP), as specified in subsection (i), shall be a physician licensed to practice medicine in all its branches pursuant to the Medical Practice Act of 1987 [225 ILCS 60]. 2)         The medical director for any Level 3 treatment service, as specified in Section 2060.410(d) through (g), shall be a physician licensed to practice medicine in all its branches pursuant to the Medical Practice Act of 1987 or a licensed advanced practice registered nurse pursuant to the requirements specified in the Nurse Practice Act [225 ILCS 65/65-43]. 3)         The medical director for any Level 1, 2, or 2.5 treatment service, as specified in 2060.410(a) through (c), shall be a physician licensed to practice medicine in all its branches pursuant to the Medical Practice Act of 1987, a licensed advanced practice registered nurse pursuant to the Nurse Practice Act, or a licensed physician assistant pursuant to the Physician Assistant Practice Act of 1987 [225 ILCS 95/1]. b)         The medical director may be full- or part-time or serve on a consulting or voluntary basis.  At the time of application for license, the DHS/SUPR Schedule E must be completed for the medical director. c)         DHS/SUPR shall be notified any time there is a change in medical director, within ten calendar days of such change.  When this occurs, a Schedule E shall also be submitted.  All Schedule Es must be kept on file by the organization and available for review upon request by DHS/SUPR. d)         The organization shall immediately notify DHS/SUPR in writing when there is a leave of absence or permanent change of the medical director. e)         The medical director and all other medical and nursing staff shall read and comply with this Part. f)         The medical director shall develop and approve all medical services for the organization and develop clinical protocol for mandated treatment as specified in Section 2060.450(b)(1). g)         The organization shall ensure that the medical director and all medical staff under the medical director's supervision comply with the requirements in Section 2060.330(b) regarding employee orientation, Sections 2060.335(a), (j), and (k) regarding personnel requirements, Section 2060.420(g)(5) regarding the Diversion Control Plan required for Opioid Treatment Programs (OTP), and Section 2060.310(g) regarding infectious disease control.